Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2022
Has the Enemy "MET" Its Match? Subgroup Analysis Results from VISION StudySamuel Rosner, Alexander I Spira
The Oncologist|August 20, 2002
The use of chemotherapy in soft-tissue sarcomasAlexander I Spira, David S Ettinger
Current Opinion in Pharmacology|August 7, 2003
Differentiation therapyAlexander I Spira, Michael A Carducci
Journal for Immunotherapy of Cancer|April 22, 2017
Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the boneSamuel Rosner, Filiz Sen, Michael Postow
Anti-Cancer Drugs|September 11, 2019
A review of canakinumab and its therapeutic potential for non-small cell lung cancerKara M Schenk, Joshua E Reuss, Karin Choquette, et al.
Annual Review of Medicine|October 26, 2018
PD-1 Blockade in Early-Stage Lung CancerSamuel Rosner, Joshua E Reuss, Patrick M Forde
Clinical Advances in Hematology & Oncology : H&O|May 28, 2024
Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?Joshua E Reuss, Samuel Rosner, Benjamin P Levy
Clinical Lung Cancer|December 12, 2025
Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLCAlexander I Spira, David Berz, Robert M Jotte, et al.
JTO Clinical and Research Reports|September 19, 2022
Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-AnalysisSamuel Rosner, Chunnan Liu, Patrick M Forde, et al.
Advances in Therapy|May 29, 2025
Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended TherapyAlexander I Spira, Tao Ran, Iris Lin, et al.
Pageof 10